Hejia Medical announced that it expects a net loss attributable to shareholders of listed companies of 339 million yuan to 439 million yuan in 2021, compared with a profit of 62.5385 million yuan in the same period last year; a net loss of 369 million yuan to 469 million yuan after deducting non-recurring gains and losses, compared with a profit of 41.5566 million yuan in the same period last year. During the reporting period, due to the impact of the epidemic and local prevention and control policies, some public hospitals were overdue. At the same time, the financial capacity of the government where the public hospital invested and built by the company deteriorated, and the collection cycle of some projects was long, and it was difficult to withdraw funds. The Company's credit impairment losses and asset impairment losses in accordance with accounting policies increased significantly compared with the same period last year.
The chairman of the company is Hao Zhenxi. Mr. Hao Zhenxi: Formerly known as Hao Wankui, born in 1968, bachelor degree, has served as assistant general manager of Zhuhai Special Economic Zone Development Co., Ltd. and sales director of Zhuhai Dongxin Instrument Co., Ltd. Since August 2007, he has served as the chairman and president of the first, second, third, fourth and fifth boards of directors of the company.
This article is compiled by the Securities Star Data Center based on publicly available data and does not constitute investment opinions or suggestions, if you have any questions, please contact us.